NEUROCRINE BIOSCIENCES INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Neurocrine Biosciences Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Neurocrine Biosciences Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 101M shares, a 3.06% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 101M +3M +3.06% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 101M +3.3M +3.38% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 101M +3.1M +3.18% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 98.7M +2.2M +2.28% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 98.2M +2.1M +2.19% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 97.6M +2M +2.09% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 97.5M +2M +2.09% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 96.5M +1.6M +1.69% Dec 31, 2022 10-K 2024-02-09
Q3 2022 96.1M +1.3M +1.37% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 95.6M +1M +1.06% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 95.5M +1M +1.06% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 94.9M +1.4M +1.5% Dec 31, 2021 10-K 2023-02-09
Q3 2021 94.8M +1.4M +1.5% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 94.6M +1.4M +1.5% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 94.5M +1.7M +1.83% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 93.5M +1.2M +1.3% Dec 31, 2020 10-K 2022-02-11
Q3 2020 93.4M +1.32M +1.43% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 93.2M +1.66M +1.82% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 92.8M +1.52M +1.66% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 92.3M +1.5M +1.66% Dec 31, 2019 10-K 2021-02-05
Q3 2019 92.1M +1.41M +1.55% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 91.5M +1.13M +1.25% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 91.3M +1.4M +1.56% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 90.8M +2M +2.26% Dec 31, 2018 10-K 2020-02-07
Q3 2018 90.7M +2.21M +2.5% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 90.4M +2.19M +2.48% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 89.9M +2.36M +2.7% Mar 31, 2018 10-Q 2018-04-30
Q4 2017 88.8M +1.91M +2.2% Dec 31, 2017 10-K 2019-02-08
Q3 2017 88.5M +1.6M +1.84% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 88.2M +1.47M +1.69% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 87.5M +947K +1.09% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 86.9M +621K +0.72% Dec 31, 2016 10-K 2018-02-13
Q3 2016 86.9M +982K +1.14% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 86.8M +1M +1.17% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 86.6M +1.2M +1.41% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 86.3M +9.8M +12.8% Dec 31, 2015 10-K 2017-02-14
Q3 2015 85.9M +9.89M +13% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 85.8M +9.83M +13% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 85.4M +9.51M +12.5% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 76.5M +9.11M +13.5% Dec 31, 2014 10-K 2016-02-11
Q3 2014 76M +8.65M +12.8% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 75.9M +8.92M +13.3% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 75.9M +9.15M +13.7% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 67.4M +904K +1.36% Dec 31, 2013 10-K 2015-02-09
Q3 2013 67.3M +962K +1.45% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 67M +678K +1.02% Jun 30, 2013 10-Q 2013-07-26
Q1 2013 66.7M +406K +0.61% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 66.4M +11.2M +20.2% Dec 31, 2012 10-K 2014-02-11
Q3 2012 66.4M +11.1M +20.1% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 66.3M +11.1M +20.1% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 66.3M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 55.3M +381K +0.69% Dec 31, 2011 10-K 2013-02-08
Q3 2011 55.3M Sep 30, 2011 10-Q 2011-10-31
Q2 2011 55.2M Jun 30, 2011 10-Q 2011-07-29
Q4 2010 54.9M Dec 31, 2010 10-K 2012-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.